Brief: Pila Pharma: Capital Infusion Via Convertible Loans

Pila Pharma AB

24/08/2023 07:24

Aug 24 (Reuters) - Pila Pharma AB  PILA.ST :
    * PILA PHARMA ANNOUNCES CAPITAL INFUSION VIA CONVERTIBLE
LOANS
    * BOARD OF PILA PHARMA HAS DECIDED TO IMMEDIATELY SECURE
ADDITIONAL FUNDS VIA CONVERTIBLE LOAN AGREEMENTS TO SPONSOR NEXT
CLINICAL TRIAL APPLICATIONS
    * WITH RECENT NEWS THAT OUR TABLETS MANUFACTURED IN 2021 ARE
CLEARED BY MANUFACTURER FOR USE IN PHASE 1 OR 2A STUDIES, PILA
PHARMA IS NOW READY TO CONTINUE CLINICAL DEVELOPMENT OF
XEN-D0501
    * NEXT STEP WILL BE TO SUBMIT 2 CLINICAL TRIAL APPLICATIONS
FOR
REGULATORY APPROVAL
    * NEW CAPITAL INFUSION WILL FUND THIS WORK THAT WILL BE
RESUMED
ASAP
    * LOANS WITH ANNUAL INTEREST RATE OF 10% P.A. ARE TO BE PAID
OUT
SHORTLY AND WILL BE CONVERTED TO SHARES AT NEXT NEW SHARES ISSUE
IN PILA PHARMA

Source text for Eikon:  ID:nBQN61G5WM 
Further company coverage:  PILA.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))